Navigation Links
Peptide Found in Human Blood Inhibits 60 Strains of HIV, Study Says

A peptide found in human blood inhibited 60 strains of HIV from infecting cells in laboratory tests, according to a study published Thursday in the journal Cell//, the San Francisco Chronicle reports. Researchers found the peptide can inhibit HIV strains that have developed resistance to existing medications --a discovery that could lead to the development of new HIV/AIDS drugs -- the Chronicle reports.

Frank Kirchhoff of the University of Ulm in Germany and colleagues found the peptide, which they call VIRIP, in the residue left in filters used by kidney dialysis patients to clean their blood. According to Kirchhoff, by altering two amino acids, VIRIP's antiviral potency increased one hundredfold. VIRIP attacks a protein, called GP-41 and found on the surface of HIV, that the virus uses to penetrate the surface of human cells, the Chronicle reports.

According to Warner Greene, director of the Gladstone Institute of Virology and Immunology who was not involved with the study, VIRIP stands out because it is collected from human blood. He added that the peptide might work synergistically with the antiretroviral drug Fuzeon, which also is known as enfuvirtide or T-20 and was approved by FDA in March 2003. Greene said that it is possible that VIRIP also has potential as an active ingredient for microbicides, which include gels, foams and creams that could be applied prior to sexual intercourse to prevent the sexual transmission of HIV and other sexually transmitted infections. VIRIP can be manufactured in lab settings and has been licensed by the German biotechnology company Viro Pharmaceuticals, whose scientific director is a co-author of the study. According to the Chronicle, Viro is conducting animal studies to determine if VIRIP is safe to test among humans.

Although the results so far "look promising," it will take at least five years of animal and human trials before a drug implementing VIRIP is available, according to Kirchhoff.
'"/>




Page: 1 2

Related medicine news :

1. New Insight To The Role Of Peptide Signals
2. Discovery of Elevated Amyloid Peptide levels could lead to Alzheimer’s Preventio
3. Fluoride Found Effective in Osteoporosis
4. Implantable Contact Lens Found Safe and Effective
5. Cancer hazard Found With Animal-Based Nutrients
6. Processed Meat, Diabetes connection Found
7. Night Time Aspirin Regimen Found to Reduce Blood Pressure
8. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
9. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
10. Preventive Therapies Found to be More Effective in Managing Migraines
11. Common Cold Found to Fight Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Peptide Found Human Blood Inhibits Strains HIV Study Says

(Date:7/23/2014)... SpaRoom® is pleased to ... and premier diffuser, is now available in sleek black, ... motor for maximum quality. The new black ultrasonic spa ... SpaRoom.com for $60 along with the traditional pearl white ... create a long-lasting, tranquil mist. Add a few drops ...
(Date:7/23/2014)... July 23, 2014 Relias Learning, the ... health and human services markets, continued to expand its ... record growth in its core markets and further expansion ... the use of SaaS-based training solutions accelerate across a ... Relias Learning. “Health and human services organizations, in particular, ...
(Date:7/23/2014)... 23, 2014 Throughout the month of July, ... plenty of new items. Also, it is hosting a couple ... its collection of short summer beach wedding dresses for ... popular styles in it. Additionally, these outfits are now offered ... , “As one of the world’s leading suppliers, LunaDress is ...
(Date:7/23/2014)... Canada (PRWEB) July 23, 2014 Princeview ... clinics, is announcing the importance of having a complete ... by a dentist to ensure oral health care, as ... examination,” says Dr. Janice Mummery, founder of Princeview Dental. ... is not able to see. Just by observing the ...
(Date:7/23/2014)... Denver, CO (PRWEB) July 23, 2014 Daily ... released a cheaper and safer alternative to Botox called ... Facial Serum is an anti-aging product used to help people ... Technology Facial Serum can be used as a safe alternative ... does not have any toxins or health risks as opposed ...
Breaking Medicine News(10 mins):Health News:SpaRoom® Unveils New Sleek Color, Improved AromaMist™ 2Health News:Relias Learning announces Q2 results - continues record growth and new market expansion 2Health News:LunaDress Continues To Enrich Product Line By Offering Short Summer Beach Wedding Dresses 2Health News:Princeview Dental, One of Etobicoke’s Trusted Dental Clinics, Addresses the Need to Have Complete Oral Exams 2Health News:Local Denver Skin Care Company Releases Safer Alternative to Botox 2
... recommended that infant be put to sleep in separate beds ... The number of infant deaths as a consequence of parents ... considerably increased over the recent years according to a report, ... weight infants, male infants and those that sleep on their ...
... melanoma among the Hispanic population of California. In a new ... a peer-reviewed journal of the American Cancer Society, the researchers ... is of the thicker variety, meaning that it has relatively ... is by far a minor percentage of all skin cancers, ...
... baby from Pakistan was given a new lease of life ... Sri M.G. Ramachandra Medical College and Hospital.// Fifteen-month-old Maxwell Qayyum ... was operated upon in Chennai, and he is reported to ... team of pediatricians conducted the surgery. ,The ...
... with pulmonary embolism can be identified through risk factors like blood ... of death due to this factor // can be treated ... Medicine. The condition is due to an abrupt blockage of an ... dislodged. In the US, this is a major health hazard. This ...
... his team from Johns Hopkins University School of Medicine ... of Medicine // that Antiretroviral combination drug of Tenofovir, ... controlling HIV load compared to most widely used drug ... trial called ‘study 934’ was conducted in 517 HIV ...
... maternity care is expected, with a London- based NHS hospital ... pregnant women who pay ?4,000. The novel scheme would be ... ,The provision of such a cost-effective one-to-one service during ... impossible to reach due to high demand. However, it continues ...
Cached Medicine News:Health News:Invasive Skin Cancer On The Rise in Hispanics 2Health News:London Hospital Provides Specialized Care For Pregnant Women 2
(Date:7/23/2014)... , July 23 2014 Ampio Pharmaceuticals, Inc. ... new headquarters, manufacturing and research facility: Ampio ... 80112 Direct: (720) 437-6500 Michael ... pharmaceutical drug manufacturing facility will be fully operational this ... first batches of Ampion TM necessary to accommodate ...
(Date:7/23/2014)... , July 23, 2014  ArmaGen, a ... therapies to treat severe neurological disorders, announced today ... and collaboration agreement with Shire plc to develop ... potential treatment of both the central nervous system ... Also known as MPS II, Hunter syndrome is ...
(Date:7/22/2014)... July 23, 2014   - Investment ... Pharmaceutical Co., Ltd. (hereinafter "Taiho"), a fully-fledged oncology pharmaceutical ... be investing US$30 million in Remiges BioPharma Fund (hereinafter ... Taiho has a long history of developing ... and cancer patients. Our development of TAS-102 is an ...
Breaking Medicine Technology:Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3Taiho Pharmaceutical Invests US$30 Million in Remiges BioPharma Fund, LP 2
... September 9, 2011 The Board of the ... today it agreed to ratify the proposal of the US ... package, designed with the help of EFCG and US industry ... User Fees Act (GDUFA). GDUFA requires the FDA ...
... Advanced Wound Management division of Smith & Nephew (LSE: SN; ... studies on a range of products and therapies from their ... RENASYS* wound care portfolio. The data demonstrate advanced healing strategies ... products. Results of the studies are being presented at the ...
Cached Medicine Technology:European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA) 2Smith & Nephew Showcases Strong Data at the Clinical Symposium on Advances in Skin & Wound Care Conference 2Smith & Nephew Showcases Strong Data at the Clinical Symposium on Advances in Skin & Wound Care Conference 3Smith & Nephew Showcases Strong Data at the Clinical Symposium on Advances in Skin & Wound Care Conference 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: